Study of Efavaleukin Alfa in Healthy Chinese, Japanese, and Caucasian Participants

Inflammatory Diseases Clinical Trial

Official title:
A Phase 1, Open-label, Sequential-group, Single-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 592 Administered Subcutaneously in Healthy Chinese, Japanese, and Caucasian Subjects

Status Completed

Clinical Trial Summary

The primary objective of this study is to evaluate the pharmacokinetics (PK) of efavaleukin alfa after single subcutaneous (SC) administration in healthy Chinese, Japanese, and Caucasian participants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Inflammatory Diseases

Clinical Trial Details

NCT number	NCT04987333
Study type	Interventional
Source	Amgen
Contact
Status	Completed
Phase	Phase 1
Start date	August 9, 2021
Completion date	October 3, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05656378` - A Repository to Study Host-Microbiome Interactions in Health and Disease
Completed	`NCT00734240` - Safety and Tolerability of Single and Multiple Doses of ISIS 353512 in Healthy Volunteers	Phase 1
Completed	`NCT03044873` - Effect of BMS-986165 on the Pharmacokinetics of Rosuvastatin	Phase 1
Terminated	`NCT01364389` - A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica	Phase 2
Recruiting	`NCT06065592` - Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms	Phase 1
Recruiting	`NCT05662033` - A Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy Subjects and to Assess the Relative Oral Bioavailability Between Two Formulations. The Study Will Also Assess the Food Effect on the PK of AZD6793 Compared to Fasting State	Phase 1
Active, not recruiting	`NCT01981785` - Investigation of Immune Disorders and Deficiencies	N/A